| Literature DB >> 35588333 |
Sudipta Kumer Mukherjee1, Daniel J Olivieri2, Sarosh Irfan Madhani3, Christopher M Bonfield4, Edith Mbabazi5, D M Arman1, Michael C Dewan6, Sheikh Muhammad Ekramullah1.
Abstract
PURPOSE: To describe the design, implementation, and adoption of a simplified electronic medical record (EMR) and its use in documenting pediatric central nervous system (CNS) tumors at a tertiary care referral hospital in South-East Asia.Entities:
Keywords: Access; Barriers; Documentation; EMR; Epidemiology; Neurosurgery
Mesh:
Year: 2022 PMID: 35588333 PMCID: PMC9118804 DOI: 10.1007/s00381-022-05450-6
Source DB: PubMed Journal: Childs Nerv Syst ISSN: 0256-7040 Impact factor: 1.532
Data characteristics
| Background characteristics | • Date of birth |
|---|---|
| Surgical information | • Reason for visit • Past medical history • Presenting symptom (s) • Surgery/operation performed • Extent of surgical resection (GTR = 1, STR = 2, Unknown = 3, Biopsy = 4, CSF-Diversion only = 5) • Additional surgeries (if applicable) • Pathological diagnosis • Tumor radiographic location • Date of discharge • Hospital length of stay (in days) |
| Follow-Up Information | • Pre-op imaging (Y/N) • Post-op imaging (Y/N) • Short-term follow-up (< 6 weeks) • Long-term follow-up (> 6 weeks) • Alive at last follow-up (Y/N) |
Demographic information
| Age, mean (range) | 8 years (range: 1 month – 13 years) |
| Sex, | |
Male Female | 147/254 (57.8%) 107/254 (42.1%) |
| Distance from NINH, mean (range) | 125 km (2–397 km) |
| Major presenting symptoms, | |
Headache/nausea/vomiting Motor weakness Visual disturbance Seizure Unknown | 95/249 (38.2%) 54/249 (21.7%) 48/249 (19.3%) 20/249 (8.0%) 32/249 (12.9%) |
| Median time from index admission to surgery | 36 days |
| Median post-operative hospital stay time | 19.5 days |
Extent of resection for operative cases, Unknown Known | 188/249 (75.5%) 138/188 (73.4%) 50/188 (26.6%) |
Additional surgeries after index surgery, Post-resection ventriculoperitoneal shunt insertion Endoscopic third ventriculostomy | 82/249 (32.9%) 58/82 (70.7%) 10/82 (12.2%) |
| Follow-up information: | |
Completed discharge date Short-term follow-up (< 6 weeks) Intermediate-term follow-up (> 6 weeks) Patients known to be alive at last follow-up | 113/249 (45.4%) 8/249 (3.2%) 17/249 (6.8%) 20/249 (8.0%) |
Radiographic location and pathology breakdown
| Radiographic location and pathology | |
|---|---|
Supratentorial Ependymoma Thalamic glioma Space occupying lesiona Meningioma Pilocytic astrocytoma DNET GBM Medulloblastoma Ganglioglioma Choroid plexus tumor Malignant small round blue cell tumor Neurofibroma Oligodendroglioma Parieto-occipital cystic lesion Temporal hemangioma | 29/212 (13.7%) 4 (13.8%) 4 (13.8%) 4 (13.8%) 2 (6.9%) 2 (6.9%) 2 (6.9%) 2 (6.9%) 2 (6.9%) 1 (3.4%) 1 (3.4%) 1 (3.4%) 1 (3.4%) 1 (3.4%) 1 (3.4%) 1 (3.4%) |
Infratentorial Space occupying lesiona Medulloblastoma Pilocytic astrocytoma Ependymoma Meningioma Hemangioma | 81/212 (38.2%) 34 (42%) 22 (27.2%) 14 (17.2%) 8 (9.9%) 2 (2.5%) 1 (1.2%) |
Suprasellar Craniopharyngioma Space occupying lesiona Germinoma Pituitary adenoma Pilocytic astrocytoma | 45/212 (21.2%) 34 (75.5%) 6 (13.3%) 2 (4.4%) 2 (4.4%) 1 (2.2%) |
Brainstem Brainstem glioma Brainstem space occupying lesiona | 6/212 (2.8%) 5 (83.3%) 1 (16.7%) |
Pineal region Space occupying lesiona Tectal glioma Pinealoblastoma | 5/212 (2.3%) 3 (60%) 1 (20%) 1 (20%) |
Intracranial NOS Low-grade astrocytoma Schwannoma Ependymoma Chordoma Ganglioglioma Glioma Germinoma Hemangiopericytoma Hemangioblastoma Hemangioma High-grade glioma Meningioma Malignant small round blue cell tumor | 25/212 (11.8%) 10 (40%) 3 (12%) 2 (8%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) |
Spinal Space occupying lesiona Spinal PDUb Spinal Extradural PDU Spinal Extradural Extramedullary PDU Spinal Intramedullary PDU Spinal Intradural Extramedullary PDU Schwannoma Astrocytoma Cavernous lymphangioma Cervical hemangioma Ganglioglioma Hemangioma Hodgkins lymphoma Non-Hodgkins lymphoma Neuroblastoma Spinal ependymoma | 20/212 (9.4%) 4 (20%) 4 (20%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 3 (15%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) 1 (5%) |
Multifocal Multifocal Germinoma | 1/212 (0.5%) 1 (100%) |
aTumors without a specified histopathological diagnosis were classified under space-occupying lesion (SOL) for each corresponding radiographic location
bTumors without specified histopathological diagnosis but classified under a sub-radiographic location were listed under Spinal Pathological Diagnosis Uncertain (PDU)